Sign in

CIK 0001281895

  • Non-accelerated filer
  • Smaller reporting company

ROCKET PHARMACEUTICALS, INC.

Sign in to watch
Ticker
RCKT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 646-440-9100
Business address
350 FIFTH AVENUE, SUITE 7530, NEW YORK, NY, 10118
Former names
INOTEK PHARMACEUTICALS CORP
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$417,906
in 7 filings

Net −$417,906. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-08-11 Stevens Christopher James Chief Operating Officer Sale −36,658 $3.50 $128K 505,784
2026-08-03 Stevens Christopher James Chief Operating Officer Grant or award +73,313 542,442
2026-08-03 Stevens Christopher James Chief Operating Officer Grant or award · Stock Option (Right to Buy) +101,428 101,428
2026-02-11 Stevens Christopher James Chief Operating Officer Grant or award +61,963 469,129
2026-02-11 Stevens Christopher James Chief Operating Officer Grant or award · Stock Option (Right to Buy) +93,037 93,037
2025-08-04 Stevens Christopher James Chief Operating Officer Grant or award +407,166 407,166
2025-08-04 Stevens Christopher James Chief Operating Officer Grant or award · Stock Option (Right to Buy) +554,071 554,071

Page 1 of 1 · 7 trades